Moreover, the positive correlation between p53 and GD3S expression in BC with hotspot p53 mutations identifies a potential source of the resistance of these cancer cells to therapeutic intervention, possibly stemming from the augmented mitochondrial activity and subsequent cellular defense against cell death, emphasizing the potential therapeutic significance of simultaneously targeting GD3S in combination with p53 reactivation strategies. This evidence concerns the gene TP53 and breast cancer.